Welcome

Welcome to Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry.

The COMPPASS Registry is a ground-breaking initiative dedicated to advancing the understanding of invasive Group B Streptococcus (iGBS) in newborns and its long-term health impacts, particularly neurodevelopmental impairment (NDI). By joining this registry, families affected by iGBS can help researchers and healthcare providers uncover vital insights into the prevention and management of this condition.